XM6MP1ICD-11 MMS 2026-01
Myelobromal
Index terms
- Myelobromal
Sibling codes
XM03S1– Phenylalanine mustardXM0569– Etirinotecan pegolXM07W3– AntramycinXM0992– IrinotecanXM0A07– CarfilzomibXM0HK3– Elliptinium acetateXM0L32– TEPAXM0N96– VismodegibXM0TE5– AzatepaXM0V25– Antineoplastic alkaloidalXM0Y26– BelinostatXM10P3– MitotaneXM1840– SelinexorXM1BM0– Talimogene laherparepvecXM1DL2– NiraparibXM1DU5– ZinostatinXM1MP7– ProcarbazineXM1NF7– VosaroxinXM1NQ8– OblimersenXM1NW0– MetoprineXM1Q78– AzaserineXM1TG4– SarkomycinXM2CG3– RazoxaneXM2D46– InproquoneXM2G84– RucaparibXM2HS5– Arsenic trioxideXM2PZ5– AnagrelideXM2Q11– MitoguazoneXM32L4– FAC (fluorouracil + doxorubicin + cyclophosphamide)XM33V8– MatulaneXM3753– IxazomibXM3A89– MitopodozideXM3BC1– AlpelisibXM3BC3– EribulinXM3L39– MOPP (mechloreth-amine + vincristine + prednisone + procarbazine)XM3MH4– Antimitotic agentXM3NJ7– BexaroteneXM3R45– LonidamineXM3RX2– Omacetaxine mepesuccinateXM3ST0– Alkylating drug antimyeloproliferativeXM3SV7– TrichlormethineXM3VC2– Sitimagene ceradenovecXM3WB5– CactinomycinXM3ZJ5– Chromic phosphate 32PXM3ZR1– TiazofurineXM40B7– Platinum compoundsXM44N1– CopanlisibXM4582– Mustard (emetic)XM4DV2– Antineoplastic combinationXM4J62– TrimustineXM4KU8– MasoprocolXM4LJ7– AsparaginaseXM4MB0– TagraxofuspXM4XD1– AfliberceptXM4ZA6– SarcolysinXM56L5– IvosidenibXM5A01– Holmium-166XM5C25– MyleranXM5DL7– IproplatinXM5FB8– TauromustineXM5FH3– TrichlorotriethylamineXM5GV6– TriethylenethiophosphoramideXM5MX5– OlivomycinXM5QR0– TalazoparibXM5UH8– Imidazole-4-carboxamideXM5VY1– Chromomycin A3XM5Z86– BortezomibXM6027– Denileukin diftitoxXM6038– GlasdegibXM6A19– Uracil mustardXM6AB6– Alkylating drugXM6AL6– PegaspargaseXM6NM1– TriethylenephosphoramideXM6Q44– Antineoplastic without further specificationXM6QJ7– PteroyltriglutamateXM6VK8– MitolactolXM6Z55– ChlorhexamideXM6ZM0– Corynebacterium parvumXM7040– PeplomycinXM7202– OlaparibXM7FX3– EntinostatXM7L47– DactinomycinXM7NL0– Phenyl hydrazine antineoplasticXM7PT2– VenetoclaxXM7R04– VorinostatXM7RN1– BelotecanXM7RS5– Cancer chemotherapy drug regimenXM7S82– PorfiromycinXM7SD2– HydroxycarbamideXM7ST9– TopotecanXM7TK6– ParoxypropioneXM7TR9– TriethanomelamineXM7WD3– BenzcarbimineXM8200– AlitretinoinXM8307– AmsacrineXM8C02– CycloleucinXM8C52– M-vacXM8F40– IdelalisibXM8NP2– EnasidenibXM8NR1– FloxuridineXM8QL8– EpacadostatXM8UF4– PlitidepsinXM8XQ7– MannomustineXM91S2– RomidepsinXM96L9– PanobinostatXM9AV3– UrethaneXM9DB5– TretinoinXM9DP5– Alkylating drug lymphaticXM9E27– SonidegibXM9F82– Anticancer agentsXM9FT7– Hormone cancer therapyXM9JX7– EstramustineXM9T22– TriethylenemelamineXM9T72– PentostatinXM9TL3– OncovinXM9TR7– RufocromomycinXM9YD3– Altretamine
Foundation entity
Part of: XM6WT8: Agents primarily affecting blood constituents or immune system › XM6S30: Medicaments › X: Extension Codes